{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-024465","form_type":"8-K","ticker":"PMI","cik":"0002030617","company_name":"Picard Medical, Inc.","filed_at":"2026-07-27T13:12:15+00:00","discovered_at":"2026-07-27T13:13:00.230545+00:00","generated_at":"2026-07-27T13:13:05.852159+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NYSE American accepts Picard Medical's compliance plan; listing continues through Nov 2027","bullets":["NYSE American accepted compliance plan under Sections 1003(a)(i) and (ii) due to low equity and losses.","Company may continue listing on NYSE American under symbol PMI while executing the plan.","Compliance period through November 8, 2027, subject to quarterly review by NYSE American.","Company must achieve milestones set forth in the compliance plan to regain full compliance.","Interim CEO Richard Fang cites progress on Emperor Total Artificial Heart and financial position."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-024465","json":"https://secwatch.observer/filing/0001437749-26-024465.json","markdown":"https://secwatch.observer/filing/0001437749-26-024465.md","text":"https://secwatch.observer/filing/0001437749-26-024465.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926024465/0001437749-26-024465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926024465/pmi20260722_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-27T13:13:05.852159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}